A champion of contemporary Indigenous artists, prolific creator across a range of media and relentless critic of dominant US ...

Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical ...

Medicenna Therapeutics Corp. begins trading today on OTCQX under the symbol “MDNAF.” U.S. inv Updated clinical results to be presented from the ongoing Phase 1/2 ABILITY-1 study of MDNA11 in ...

to treat breast cancer and other solid tumors; and RAD 301, a diagnostic radiopharmaceutical targeting avß6 integrin in pancreatic ductal adenocarcinoma patients. The company also develops RAD ...

As she battled a rare sarcoma cancer over the last two years of her life, Manheim Township resident Ginny McCreary struggled ...

TriSalus Life Sciences® Inc. , is announcing preliminary unaudited fourth quarter and full year 2024 financial results and details of the upcoming conference call. Preliminary Unaudited Fourth Quarter ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five ...

The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

The new findings show the cancer mortality rate declined by 34% from 1991 to 2022 in the United States, averting ... Experimental Blood Test for Pancreatic Cancer Undergoing Clinical Development ...

Ajay Goel, PhD, AGAF, discusses how the development and validation of novel non-invasive biomarkers can improve early detection and ultimately impact patient outcomes for patients.